Praxis Launches Second Patient Recruitment Campaign for a Type 2 Diabetes Study Utilizing an Innovative New Insulin

Brentwood, TN -- June 1, 2006 -- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a major pharmaceutical company for a medical research study.  The enrollment will take place in 35 sites across the United States.  The recruitment period will run about nine months for this Phase III b study, which will provide research on a unique non-invasive insulin delivery system for type 2 diabetes.

The integrated marketing campaign developed by Praxis includes a combination of novel targeted message delivery tactics along with recruitment materials for the sites and community outreach.  Through the study’s website and a toll-free number, all inquiries will flow into the centralized recruitment center and will be tracked via PraxisDirect®. 

David Fox, president and CEO of Praxis. “This study represents Praxis’ ongoing commitment to deliver a targeted strategic campaign that meets or exceeds our client’s recruitment deadlines, and will achieve positive results supporting the introduction of this new medication that could help millions of people with diabetes.”

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management.  For more information, call Praxis at (615) 312-8207.

> Back to Press Releases